Predictive Oncology enters $10M standby equity purchase agreement with YA II PN

Axe Compute Inc.

• Company can sell up to $10M of common stock at 96% of lowest 3-day VWAP over 36 months.
• Paid $25,000 structuring fee and issued 120,482 common shares as a 1% commitment fee.
• Exchange cap of 1,921,706 shares (19.99% of outstanding) unless stockholder approval or average price >= $0.83.
• Investor ownership limited to 4.99% of outstanding; proceeds for working capital and general purposes.
• Registration statement required before any advances; no mandatory minimum draws or non-usage fees.